Pancreatic Cancer Research

ResearcherHeidelberg UniversityActive in the last 2 years

Miriam Schenk

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0208-7958; OpenAlex author ID A5026910009. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 8

  1. Blood-based prediction and early detection of pancreatic cancer recurrence after tumor resection Co-author DOI 10.20892/j.issn.2095-3941.2025.0495↗
  2. Combined analysis of a serum mRNA/miRNA marker signature and CA 19-9 for timely and accurate diagnosis of recurrence after resection of pancreatic ductal adeno… Co-author DOI 10.1002/ueg2.12676↗
  3. Structural expression of bovine milk and meat factors in tissues of colorectal, lung and pancreatic cancer patients. Co-author DOI 10.1002/ijc.34374↗
  4. Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system. Co-author DOI 10.1186/s13046-022-02519-7↗
  5. Deep molecular characterization linked to drug response profiling of pancreatic ductal adenocarcinoma using patient-derived organoids Co-author DOI 10.1101/2021.08.26.457743↗
  6. Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer. Co-author DOI 10.3390/v13061019↗
  7. Role of TFEB-driven autophagy regulation in pancreatic cancer treatment. Co-author DOI 10.3892/ijo.2016.3505↗
  8. Salinomycin inhibits growth of pancreatic cancer and cancer cell migration by disruption of actin stress fiber integrity. Co-author DOI 10.1016/j.canlet.2014.12.037↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Markus Wolfgang Büchler · 5 shared papers, 2021–2026 · strength 0.85
  2. Nathalia A. Giese · 5 shared papers, 2015–2025 · strength 0.64
  3. Thilo Hackert · 2 shared papers, 2025–2026 · strength 0.46
  4. Mohamed Saiel Saeed Alhamdani · 1 shared paper, 2026 · strength 0.25
  5. Fawaz N. Al-Shaheri · 1 shared paper, 2026 · strength 0.25
  6. Andrea S. Bauer · 1 shared paper, 2026 · strength 0.25
  7. Jörg D. Hoheisel · 1 shared paper, 2026 · strength 0.25
  8. Ulrike Heger · 1 shared paper, 2026 · strength 0.25
  9. Solange Le Blanc · 2 shared papers, 2021–2022 · strength 0.25
  10. Sebastian Schuth · 2 shared papers, 2021–2022 · strength 0.25
  11. Christian Conrad · 2 shared papers, 2021–2022 · strength 0.25
  12. Oliver Strobel · 2 shared papers, 2021–2022 · strength 0.25
  13. Michael Volkmar · 2 shared papers, 2021 · strength 0.21
  14. Malte Buchholz · 1 shared paper, 2025 · strength 0.21
  15. Hans Armin Kestler · 1 shared paper, 2025 · strength 0.21
  16. Rita Teresa Lawlor · 1 shared paper, 2025 · strength 0.21
  17. Núria Malats Riera · 1 shared paper, 2025 · strength 0.21
  18. Alfredo Carrato Mena · 1 shared paper, 2025 · strength 0.21
  19. Thomas Mathias Gress · 1 shared paper, 2025 · strength 0.21
  20. Aldo Scarpa Scarpa · 1 shared paper, 2025 · strength 0.21
  21. Julie Earl · 1 shared paper, 2025 · strength 0.21
  22. Teresa G. Krieger · 1 shared paper, 2022 · strength 0.15
  23. Emrullah Birgin · 1 shared paper, 2023 · strength 0.14
  24. Nuh N. Rahbari · 1 shared paper, 2023 · strength 0.14
  25. Harald zur Hausen · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.